banner
EGFR-HER2 inhibitor Erlotinib, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ1059

EGFR-HER2 inhibitor Erlotinib, Purity ≥98%

Synonym: Erlotinib; 183321-74-6; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine; Tarceva; Erlotinib free base; 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; EGFR-HER2 inhibitor

  • MDL: MFCD02089651
  • CAS Number: 183321-74-6
  • Compound CID: 176870
img
Product Size
5 g; 10 g; 20 g
Price
Datasheet
MSDS
Properties
Description
Erlotinib, soluble in DMSO and warmed ethanol and insoluble in water, is a potent and specific inhibitor of the tyrosine kinase activity of EGFR. It targets EGFR.
Molecular Weight
393.443
Molecular Formula
C22H23N3O4
Targets
EGFR: 2 nM (IC50, cell free assay)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 68 mg/mL (172.83 mM); Water: Insoluble; Warmed ethanol: 13 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
Erlotinib can be used to study the inhibition of EGFR tyrosine kinase in cancer research.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0